OBJECTIVES/ INTRODUCTION: Demand for nursing home (NH) care by patients with end-stage renal disease (ESRD) is likely to increase with growing numbers of older adults initiating chronic dialysis. We completed a systematic review to summarize the literature on NH residents with ESRD. METHODS: MEDLINE, CINAHL, EMBASE, and relevant conference proceedings were searched to identify articles using the following MESH terms or related key words in the title or abstract: "residential facilities", "renal dialysis", "renal replacement therapy", and "chronic kidney failure". We selected case control, cohort studies, and clinical trials that included older adults with ESRD (defined as those receiving chronic dialysis or those with stage 5 chronic kidney disease) living in residential care facilities. We abstracted information on study design, quality, and results. RESULTS: Of 198 unique citations identified by the search strategy, 14 articles met eligibility criteria. Most articles were multicenter studies that were conducted in the 1990 s. One study focused on patients with stage 5 chronic kidney disease, and the remaining 13 studies focused on patients receiving chronic dialysis, of which eight studies included only those receiving peritoneal dialysis, four studies included patients receiving both peritoneal dialysis and hemodialysis, and one study included only patients receiving hemodialysis. All studies were observational, no clinical trials were identified, and study design limitations and heterogeneity within study populations were common. Summarizing results across these studies suggests that NH residents with ESRD have limited survival, particularly early after dialysis initiation. Functional impairment is highly prevalent in this population and independently associated with poor outcomes. CONCLUSIONS: NH residents with ESRD appear to be a particularly vulnerable population, but current information on their prevalence, characteristics, and outcomes is limited. Further research is needed to provide a better understanding of modifiable predictors of survival and functional decline in this population.
OBJECTIVES/ INTRODUCTION: Demand for nursing home (NH) care by patients with end-stage renal disease (ESRD) is likely to increase with growing numbers of older adults initiating chronic dialysis. We completed a systematic review to summarize the literature on NH residents with ESRD. METHODS: MEDLINE, CINAHL, EMBASE, and relevant conference proceedings were searched to identify articles using the following MESH terms or related key words in the title or abstract: "residential facilities", "renal dialysis", "renal replacement therapy", and "chronic kidney failure". We selected case control, cohort studies, and clinical trials that included older adults with ESRD (defined as those receiving chronic dialysis or those with stage 5 chronic kidney disease) living in residential care facilities. We abstracted information on study design, quality, and results. RESULTS: Of 198 unique citations identified by the search strategy, 14 articles met eligibility criteria. Most articles were multicenter studies that were conducted in the 1990 s. One study focused on patients with stage 5 chronic kidney disease, and the remaining 13 studies focused on patients receiving chronic dialysis, of which eight studies included only those receiving peritoneal dialysis, four studies included patients receiving both peritoneal dialysis and hemodialysis, and one study included only patients receiving hemodialysis. All studies were observational, no clinical trials were identified, and study design limitations and heterogeneity within study populations were common. Summarizing results across these studies suggests that NH residents with ESRD have limited survival, particularly early after dialysis initiation. Functional impairment is highly prevalent in this population and independently associated with poor outcomes. CONCLUSIONS: NH residents with ESRD appear to be a particularly vulnerable population, but current information on their prevalence, characteristics, and outcomes is limited. Further research is needed to provide a better understanding of modifiable predictors of survival and functional decline in this population.
Authors: Naveen C Reddy; Stephen M Korbet; Julie A Wozniak; Sheri L Floramo; Edmund J Lewis Journal: Nephrol Dial Transplant Date: 2007-01-27 Impact factor: 5.992
Authors: John Schnelle; Dan Osterweil; Denise Globe; Angela Sciarra; Paul Audhya; Arie Barlev Journal: J Am Med Dir Assoc Date: 2008-12-20 Impact factor: 4.669
Authors: Manjula Kurella Tamura; Kenneth E Covinsky; Glenn M Chertow; Kristine Yaffe; C Seth Landefeld; Charles E McCulloch Journal: N Engl J Med Date: 2009-10-15 Impact factor: 91.245
Authors: Robert Nee; John S Thurlow; Keith C Norris; Christina Yuan; Maura A Watson; Lawrence Y Agodoa; Kevin C Abbott Journal: J Am Med Dir Assoc Date: 2019-03-28 Impact factor: 7.802
Authors: C Barrett Bowling; Rebecca Zhang; Harold Franch; Yijian Huang; Anna Mirk; William M McClellan; Theodore M Johnson; Nancy G Kutner Journal: BMC Nephrol Date: 2015-03-21 Impact factor: 2.388
Authors: Caroline M Hsu; Daniel E Weiner; Gideon Aweh; Dana C Miskulin; Harold J Manley; Carol Stewart; Vlad Ladik; John Hosford; Edward C Lacson; Douglas S Johnson; Eduardo Lacson Journal: Am J Kidney Dis Date: 2021-01-17 Impact factor: 8.860
Authors: Mohammadali Tofighi; Ali Asgary; Asad A Merchant; Mohammad Ali Shafiee; Mahdi M Najafabadi; Nazanin Nadri; Mehdi Aarabi; Jane Heffernan; Jianhong Wu Journal: PLoS One Date: 2021-11-19 Impact factor: 3.240
Authors: Eran Y Bellin; Alice M Hellebrand; Steven M Kaplan; Jordan G Ledvina; William T Markis; Nathan W Levin; Allen M Kaufman Journal: Hemodial Int Date: 2021-06-16 Impact factor: 1.812